Aug 11, 2026 04:05PM
Jun 14, 2026 02:01PM
Jun 14, 2026 10:00AM
Jun 8, 2026 07:00AM
Jun 3, 2026 06:01AM
Jun 3, 2026 06:00AM
Jun 1, 2026 01:46PM Jefferies on Mineralys Therapeutics, Inc. (MLYS): 'Historical Trends Suggests M&A Is Still Statistically Possible Before PDUFA'
May 30, 2026 11:15AM
May 30, 2026 11:15AM
May 30, 2026 11:15AM
May 18, 2026 04:05PM
May 18, 2026 04:05PM
May 6, 2026 04:05PM
Mar 24, 2026 08:00AM Mineralys Therapeutics names Jeffrey Munsie as chief legal officer
Mar 24, 2026 08:00AM
Mar 13, 2026 07:59AM
Mar 12, 2026 04:05PM
Mar 10, 2026 09:32AM
Mar 10, 2026 06:12AM
Mar 9, 2026 04:30PM
Mar 3, 2026 05:31PM Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Jan 6, 2026 08:00AM
Dec 12, 2025 11:00AM
Dec 12, 2025 11:00AM
Nov 10, 2025 04:05PM
Nov 7, 2025 06:10PM
Oct 21, 2025 08:00AM
Oct 21, 2025 08:00AM Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025
Sep 30, 2025 08:01AM
Sep 30, 2025 08:00AM
Sep 8, 2025 07:13AM
Sep 5, 2025 09:00AM
Sep 5, 2025 09:00AM
Aug 12, 2025 04:05PM
Jul 14, 2025 08:20AM Jefferies Reiterates Hold Rating on Mineralys Therapeutics, Inc. (MLYS)
Jun 30, 2025 11:19AM
Jun 30, 2025 11:17AM
Jun 18, 2025 06:44AM
Jun 17, 2025 07:00AM
Jun 17, 2025 07:00AM
May 24, 2025 04:30AM
May 20, 2025 08:01AM Mineralys Therapeutics (MLYS) Announces Late-Breaking Presentation of Phase 3 Launch-HTN Trial at 34th European Meeting on Hypertension and Cardiovascular Protection
May 20, 2025 08:00AM
May 12, 2025 04:05PM
Apr 23, 2025 05:25PM
Apr 23, 2025 05:23PM
Mar 29, 2025 02:30PM
Mar 17, 2025 08:00AM
Mar 17, 2025 08:00AM Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College
Mar 10, 2025 07:01AM

328,334 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All